医学
STK11段
免疫疗法
克拉斯
内科学
肿瘤科
癌症
结直肠癌
作者
Andrea De Giglio,Dario de Biase,Valentina Favorito,Thais Maloberti,Alessandro Di Federico,Federico Zacchini,Giulia Venturi,Claudia Parisi,Filippo Gustavo Dall’Olio,Ilaria Ricciotti,Ambrogio Gagliano,Barbara Melotti,Francesca Sperandi,Annalisa Altimari,Elisa Gruppioni,Giovanni Tallini,Francesco Gelsomino,Lorenzo Montanaro,Andrea Ardizzoni
出处
期刊:Lung Cancer
[Elsevier BV]
日期:2024-12-20
卷期号:199: 108058-108058
被引量:9
标识
DOI:10.1016/j.lungcan.2024.108058
摘要
STK11 aberrations hampered the mOS of nsq NSCLC patients treated with first-line ICI or CT-ICI. The negative prognostic impact seems to be unrelated to ICI administration.
科研通智能强力驱动
Strongly Powered by AbleSci AI